1. Overexpression of Bruton Tyrosine Kinase Inhibits the Proliferation, Migration, and Invasion of Non-Small Cell Lung Cancer Cells
   Wenjia Ren et al, 2023, Analytical Cellular Pathology CrossRef
2. Metronomic Chemotherapy for Metastatic Breast Cancer Treatment: Clinical and Preclinical Data between Lights and Shadows
   Marina Elena Cazzaniga et al, 2022, Journal of Clinical Medicine CrossRef
3. BTK Expression Level Prediction and the High-Grade Glioma Prognosis Using Radiomic Machine Learning Models
   Chenggang Jiang et al, 2024, Journal of Imaging Informatics in Medicine CrossRef
4. Bruton’s Tyrosine Kinase Inhibitors (BTKIs): Review of Preclinical Studies and Evaluation of Clinical Trials
   Dariusz Rozkiewicz et al, 2023, Molecules CrossRef
5. Structural Complementarity of Bruton’s Tyrosine Kinase and Its Inhibitors for Implication in B-Cell Malignancies and Autoimmune Diseases
   Asim Najmi et al, 2023, Pharmaceuticals CrossRef
6. EF‐24 inhibits TPA‐induced cellular migration and MMP‐9 expression through the p38 signaling pathway in cervical cancer cells
   Chung‐Yuan Lee et al, 2023, Environmental Toxicology CrossRef
7. Recent development of BTK-based dual inhibitors in the treatment of cancers
   Fansheng Ran et al, 2022, European Journal of Medicinal Chemistry CrossRef
8. Combining structure-based pharmacophore modeling and machine learning for the identification of novel BTK inhibitors
   Tanuj Sharma et al, 2022, International Journal of Biological Macromolecules CrossRef